Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm

September 20, 2012

WILMINGTON, Mass., Sept. 20, 2012 /PRNewswire/ — NeuroTherm(® )announced today that Gregory D. Cash has been appointed as President and Chief Executive Officer. He will also serve on the board of directors of NeuroTherm effective immediately.

Greg joins NeuroTherm with more than 30 years of successful, results-oriented experience in the medical device industry. He most recently served as President and Chief Executive Officer of HeartSine Technologies. Prior to HeartSine, Greg served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.

“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg’s leadership combined with his strategic vision and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, Chairman of the Board of Directors and Senior Managing Director of Linsalata Capital Partners. “We are delighted to have Greg as our new CEO and member of the Board.”

“I am excited and honored to have been asked to lead NeuroTherm. The company is known for providing exceptional customer service and safe, reliable and effective products,” said Cash. “While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients’ lives.”

NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain Management, including radio frequency generators and related consumables used in the treatment of chronic pain. The company was awarded a US Patent #7,574,257 in recognition of the first multi-lesion radiofrequency generator on the market. NeuroTherm markets and sells to Interventional Pain, Interventional Radiology, and Orthopedics.

NeuroTherm is based in Wilmington, Massachusetts with corporate offices in London, UK, Germany and Amsterdam, NL. Additional information about NeuroTherm can be found on at www.neurotherm.com.

SOURCE NeuroTherm


Source: PR Newswire